I recently had the privilege of sitting through four investigator meetings, two in the United States and two in Europe. They comprised speaker after speaker with slide after slide. Topics included the disease, the drug, the PK, the efficacy and
You may be aware that I’ve been going to investigator meetings and finding them kind of out-of-date. We’ve got to get away from what’s easy for the sponsor, and instead move toward what is effective for the investigators and their
Ironically enough, the biggest challenge faced by people making scientific and technical presentations is their reluctance to follow the scientifically established principles of communication. What are those rules? One of them is that the human mind is drawn to problems,